| |
| |
|
| Insider
Information: |
Prestrelski Steven |
| Relationship: |
Chief Scientific Officer |
| City: |
Chicago |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xeris Pharmaceuticals Inc |
XERS |
Chief Scientific Officer |
2021-10-05 |
0 |
2018-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(494,780) |
0 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-04-12 |
4 |
AS |
$4.07 |
$40,725 |
D/D |
(10,000) |
496,824 |
0 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
506,824 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-13 |
4 |
AS |
$6.01 |
$60,058 |
D/D |
(10,000) |
406,824 |
0 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-11 |
4 |
AS |
$5.72 |
$57,244 |
D/D |
(10,000) |
416,824 |
0 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
426,824 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
436,824 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-01-13 |
4 |
AS |
$5.50 |
$54,992 |
D/D |
(10,000) |
421,824 |
0 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-11-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,500 |
431,824 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-10-11 |
4 |
AS |
$7.97 |
$79,746 |
D/D |
(10,000) |
449,324 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-07-11 |
4 |
AS |
$12.04 |
$120,395 |
D/D |
(10,000) |
459,324 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-04-11 |
4 |
AS |
$9.56 |
$95,649 |
D/D |
(10,000) |
477,024 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-01-14 |
4 |
AS |
$17.20 |
$132,459 |
D/D |
(7,700) |
469,324 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-01-11 |
4 |
AS |
$0.00 |
$0 |
D/D |
(2,300) |
487,024 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-12-26 |
4 |
S |
$15.82 |
$248,738 |
D/D |
(15,720) |
489,324 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-12-24 |
4 |
OE |
$1.19 |
$18,707 |
D/D |
15,720 |
505,044 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
37,362 |
489,323 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
